Related by context. All words. (Click for frequent words.) 68 Sipuleucel T 67 Pertuzumab 66 Epidermal Growth Factor Receptor 66 Tumor Response 66 Cardiotoxicity 66 TLR9 agonists 66 Rigel R# 65 Pemetrexed 65 interferon γ 65 Traficet EN 65 Degarelix 65 Aurora Kinase 65 chemokine receptor 65 aT cell 65 IFN α 65 CCX# 64 SYN# 64 VEGF receptor 64 EBMT criteria 64 Decitabine 64 G#DT 64 DNA intercalator 64 azacytidine 64 IAP inhibitor 64 thalidomide Thalomid 64 Enzastaurin 64 targeting CD# 63 ASCO abstract 63 selective inhibition 63 tumor antigen 63 histone deacetylase HDAC 63 liposomal formulation 63 Pralatrexate 63 MAGE A3 ASCI 63 Sudhir Agrawal D.Phil 63 Gleevec resistant 63 Anticalin ® 63 TLR antagonists 63 HuMax EGFr 63 Epratuzumab 63 Teriflunomide 63 Corgentin 63 EGFR HER2 63 EGFr 63 Galectin 63 antiangiogenic agent 63 ZFP TF 63 CIMZIA ™ 63 Trastuzumab 63 allergic airway inflammation 63 Oral NKTR 63 Interferon beta 63 proteasome inhibitor 63 Vandetanib 63 vascular disrupting agents 63 thrombin receptor 63 CYT# potent vascular disrupting 63 Tumor Necrosis Factor 63 Golimumab 63 GW# [003] 63 BiTE 62 TLR7 62 vidofludimus 62 Aflibercept 62 florbetaben 62 TNF α 62 IL 1ß 62 sorafenib tablets 62 SPRYCEL ® 62 Cytochrome P# 62 OMP #M# 62 Glufosfamide 62 novel prodrug 62 Vitaxin 62 Trp p8 62 Chemokine Receptor 62 Bortezomib 62 metastatic neuroendocrine tumors 62 XYOTAX TM 62 Ocrelizumab 62 PROCHYMAL 62 Bosutinib 62 TLR9 agonist 62 receptor tyrosine kinase inhibitor 62 Follicular Lymphoma 62 MGd 62 PrevOnco 62 Solid Tumors 62 monocytes macrophages 62 ACZ# 62 galiximab 62 murine models 62 HCV replicon 62 Daclizumab 62 IgG1 antibody 62 Carfilzomib 62 Signaling Pathway 62 Estrogen Receptor 62 Archexin 62 antifibrotic 62 hypereosinophilic syndrome 62 HER2 receptor 62 TLR9 mediated immune 62 investigational humanized monoclonal antibody 62 SynCon ™ DNA 62 sipuleucel T 62 Anti Tumor 62 Aplidin R 62 Dapagliflozin 62 Mucosal 62 immunostimulatory 62 Muraglitazar 62 relapsed MM 62 alefacept 62 novel VDA molecule 62 5 HT4 62 Receptor Antagonists 62 serotonin receptor 62 Interferon Gamma 62 targeted antifolate 62 HuMax 62 TYKERB 62 depsipeptide 62 Dalbavancin 62 VitiGam 62 Dasatinib 62 rilonacept 62 KRN# 61 Sapacitabine 61 liposomal doxorubicin 61 Cytotoxic T 61 NF kB pathway 61 Protein Kinase C 61 peptide antigens 61 Irinotecan 61 Photodynamic therapy PDT 61 NEUGENE 61 Tyrosine Kinase Inhibitor 61 Aliskiren 61 Angiolix 61 Nanobody 61 dasatinib Sprycel ® 61 interleukin IL -# 61 Bevacizumab 61 5 HT2A 61 Ataluren 61 annexin V 61 TNFa 61 pain palliation 61 levodopa induced dyskinesia 61 HDAC Inhibitor 61 Dacogen decitabine 61 ENMD # 61 K ras mutations 61 targeted radiotherapeutic 61 Janus Kinase 61 tyrosine kinase inhibitor 61 crizotinib PF # 61 immune modulatory 61 mecamylamine 61 Fingolimod 61 C5a 61 ganetespib 61 multiple myeloma MM 61 Universal Flu Vaccine 61 T#I [002] 61 PI3K/Akt pathway inhibitor 61 antitumoral 61 BRIM2 61 TLR9 61 Guanilib 61 anti angiogenic agent 61 SCCHN 61 ON #.Na 61 pDCs 61 protein tyrosine phosphatase 1B 61 Ecallantide 61 IGF IR 61 protein kinase inhibitors 61 tocilizumab 61 drotrecogin alfa activated 61 Romiplostim 61 Hsp# Inhibitor 61 glycopeptide 61 chimeric monoclonal antibody 61 CB1 antagonists 61 Pegylated Liposomal Doxorubicin 61 Chronic HCV 61 Rituximab 61 Dendritic cell 61 Anti TNF 61 SGLT2 inhibitors 61 DEB# 61 endogenous ligands 61 immunomodulator 61 Diabetic Neuropathy 61 Neuvenge 61 Panzem R NCD 61 potent cytotoxic 61 FLT3 61 selective modulator 61 CXCR4 receptor 61 histone deacetylase HDAC inhibitor 61 Peginterferon Alfa 2a 61 ALB # 61 EGFR pathway 61 fluoropyrimidine 61 Fulvestrant 61 prognostic markers 61 BRAF inhibitors 61 Initiated Phase 60 Hormone Refractory Prostate Cancer 60 IgG1 monoclonal antibody 60 Janus kinase 60 cytoprotective 60 Abatacept 60 PARP inhibitor 60 Diffuse Large B 60 ZOLINZA 60 KRAS mutation 60 PEG interferon 60 tigecycline 60 Everolimus 60 cytokine signaling 60 Pharmacokinetics PK 60 TransVax tm 60 TNFalpha 60 imatinib Gleevec ® 60 Methylnaltrexone 60 Xanafide 60 Natalizumab 60 Lipsovir ® 60 Talabostat 60 HuLuc# 60 gefitinib Iressa 60 solithromycin 60 pan HDAC inhibitor 60 ALK inhibitor 60 EMBLEM TM 60 EndoTAGTM 1 60 antiproliferative effects 60 HER2 overexpression 60 angiotensin receptor 60 assessing T DM1 60 CD# antibodies 60 progesterone receptor 60 heparanase 60 Cyclooxygenase 2 60 Vidofludimus 60 HTS assay 60 Zarnestra 60 Targeted Therapy 60 HIF PH inhibitors 60 Tarvacin 60 Ambrisentan 60 DCVax R 60 cMET 60 TEMODAL 60 plasma kallikrein inhibitor 60 endogenous interferon alpha 60 PI3K Akt 60 effector function 60 Seliciclib 60 Temsirolimus 60 Antisoma AS# 60 pomalidomide 60 vorinostat 60 MET amplification 60 preclinical efficacy 60 adalimumab Humira 60 beta 1a 60 Interferon Beta 60 Preclinical Study 60 JAK Inhibitor 60 antiapoptotic 60 sunitinib Sutent 60 Accelerated Approval 60 mGlu2 3 60 Blinatumomab 60 Aplidin 60 5alpha reductase 60 ATL# [001] 60 sCD# 60 immunomodulatory 60 histamine dihydrochloride 60 folate receptor 60 Monoclonal antibody 60 enzastaurin 60 novel oral anticoagulant 60 BAL# [002] 60 selective agonists 60 Novel Antibiotic 60 Alequel 60 NY ESO 60 Cathepsin B 60 vinorelbine tartrate 60 Amplimexon 60 Dose Escalation 60 DermaVir Patch 60 MAb 60 galectin 60 Liposomal 60 hA# 60 mycophenolate mofetil 60 haematologic 60 hypoxic tumors 60 androgen receptor AR 60 Meets Primary Endpoint 60 Src kinases 60 Cimzia ® certolizumab pegol 60 PDGF receptor 60 Angiocept 60 TIMP 1 60 Noxafil 60 Immunosuppression 60 PSMA ADC 60 BioMAP 60 serum antibody 60 selective serotonin 2C receptor 60 Preclinical Data 60 refractory metastatic 60 trastuzumab Herceptin 60 GRNCM1 60 Azedra 60 colorectal carcinomas 60 Pharmacokinetic Study 60 kidney urologic 60 intratumoral injection 60 accumulate preferentially 60 Symadex 60 humanized antibody 60 mTOR inhibitor 60 downstream effector 60 ixabepilone 60 Doxil ® 60 HER2/neu 60 Antitumor Activity 60 Pharmacokinetic PK 60 TG# [003] 60 milatuzumab 60 IFN β 60 mTOR inhibitors 60 antiangiogenic therapy 60 YONDELIS 60 bortezomib Velcade 60 Anticalins ® 60 A3 adenosine receptor 60 miR #a [002] 60 preclinically 60 basiliximab 60 flavopiridol 60 Capecitabine 60 Roflumilast 60 ImmuKnow R 60 erlotinib Tarceva 60 tipranavir ritonavir 60 FOLPI 60 Epirubicin 60 annexin 60 Cyclosert 60 Virulizin ® 60 oral JAK1 60 tumorigenicity 60 psoriasis rheumatoid arthritis 60 viral kinetics 60 Abstract Number 60 Quinamed 60 PEG SN# 60 Panzem 60 CCR5 receptor antagonist 60 EOquin TM 60 Deforolimus 60 Squalamine 60 Kahalalide F 59 ZACTIMA 59 leukotriene receptor antagonist 59 Aptamer 59 chemosensitivity 59 SGLT 2 59 cannabinoid receptor 59 protein tyrosine phosphatases 59 BRAF inhibitor 59 CYP#A# CYP#D# 59 etanercept Enbrel 59 Antiangiogenic 59 Cinacalcet HCl 59 p# biomarker 59 AT1R 59 Sphingomab 59 MYCAMINE 59 bevacizumab Avastin ® 59 Recombinant Human 59 IGF 1R 59 CD# monoclonal antibody 59 HCV Genotype 59 generation antisense inhibitor 59 Alequel ™ 59 Tesmilifene 59 UPLYSO 59 beta interferons 59 sodium glucose cotransporter 59 molecular chaperone regulator 59 M1 muscarinic 59 riociguat 59 LPS induced 59 pharmacodynamic properties 59 Safinamide 59 neuronal nicotinic receptor NNR 59 SIR Spheres 59 investigational immunotherapy 59 R roscovitine 59 Trofex 59 mRCC 59 Therapeutic Vaccine 59 Erlotinib 59 fusion enhancers 59 multi kinase inhibitor 59 IL2 59 oral prodrug 59 Castration Resistant Prostate Cancer 59 ALK inhibitors 59 mertansine 59 biologic DMARD 59 Xelox 59 Systemic Delivery 59 Cytotoxic 59 IL6 59 Ramelteon 59 TGF β 59 briakinumab 59 Late Breaker 59 CCR5 co 59 immunoregulatory 59 Oral Fingolimod 59 Vidaza azacitidine 59 apremilast 59 Diabetic Foot Ulcer 59 TOP2A 59 peptibody 59 Exelixis XL# 59 Cutaneous T 59 Recurrent Glioblastoma 59 TGFβ 59 kinase inhibition 59 Factor VIIa 59 compound AEZS 59 antiepileptics 59 Interferon gamma 59 icatibant 59 humanized monoclonal antibody 59 immunotoxin 59 TLK# 59 Multimeric 59 5 HT2A serotonin 59 Upregulation 59 Exemestane 59 Fludarabine 59 DiLA2 59 Mycophenolate Mofetil 59 pegylated alpha interferon 59 oral kinase inhibitor 59 busulfan 59 olmesartan 59 inhibit metastasis 59 dasatinib Sprycel 59 estrogen receptor beta 59 Gastrointestinal Stromal Tumors 59 Initiate Clinical Trial 59 Paraplatin ® 59 AZILECT ® 59 Lenalidomide 59 HQK 59 #F FDG PET 59 Tesetaxel 59 Antiviral Therapy 59 humanized monoclonal antibodies 59 Interferon alfa 59 HDACi 59 Glucocorticoid 59 Schizophrenia Treatment 59 ACR# [001] 59 recurrent glioma 59 orally administered inhibitor 59 antibody mediated 59 Davanat 59 novel immunotherapeutic 59 RhuDex 59 ALGRX 59 Onconase 59 Randomized Phase 59 biologic therapy 59 sorafenib Nexavar 59 masitinib 59 Mipomersen 59 PDE4 inhibitor 59 Onrigin 59 Drug Candidate 59 cyclin dependent kinase CDK 59 imatinib mesylate Gleevec 59 antiangiogenesis 59 Denufosol 59 investigational monoclonal antibody 59 NK1 59 OHR/AVR# 59 Kinase Inhibitor 59 CCR5 antagonist 59 beta lactamase inhibitor 59 Bosentan 59 antiplatelet therapies 59 ADVEXIN 59 Vimpat R 59 Nanobodies 59 investigational therapies 59 cytokine interleukin 59 polycythemia vera PV 59 Vaprisol 59 bispecific 59 EZN 59 proteasome inhibitors 59 Personalized Immunotherapy 59 alkylating agent 59 abnormal p# 59 delipidation 59 Photodynamic therapy 59 Prospective Randomized 59 RhuDex ® 59 Darunavir 59 selectively inhibited 59 hepatoma 59 p# inhibitor 59 factor TNF 59 IRX 2 59 fosbretabulin 59 small molecule Hedgehog 59 Telbivudine 59 B lymphocyte stimulator 59 Capesaris 59 ADVEXIN therapy 59 immunomodulatory agents 59 QuadraSphere 59 alpha TNFa 59 microtubule targeting 59 anti CD3 59 NM# [003] 59 Romidepsin 59 sargramostim 59 NKX#.# 59 pharmacodynamic parameters 59 DAVANAT 59 ongoing Phase 1b 59 Tasigna nilotinib 59 mapatumumab 59 xenograft models 59 Pirfenidone 59 Phase 2a Trial 59 KSP inhibitor 59 Posaconazole 59 Akt phosphorylation 59 chemotherapeutic regimen 59 Vascugel ® 59 Pancreate 59 Dendreon Provenge 59 Monocyte 59 CIMZIA TM 59 Pegylated 59 Ranolazine 59 Aviptadil 59 pertuzumab 59 LHRH antagonist 59 Genentech Rituxan 59 LY# [002] 59 interferon IFN 59 virus HCV protease inhibitor 59 imatinib resistance 59 CYT# QbG# 59 DNA methylation markers 59 Chemetics R 59 aurora kinase 59 Malignant Glioma 59 TNFα 59 subcutaneous ORENCIA 59 miRview mets 59 Melphalan 59 Pazopanib 59 p# MAPK 59 Rasilamlo 59 PROSTVAC TM 59 MET VEGFR2 58 adenosine receptor 58 Rasagiline 58 Myelodysplastic Syndrome 58 Refractory Angina 58 paclitaxel Taxol 58 Adrenergic 58 thymalfasin 58 ALN TTR 58 Receptor Agonist 58 histone deacetylase inhibitor 58 tyrosine kinase inhibitors TKIs 58 Fas ligand 58 fludarabine cyclophosphamide 58 metaglidasen 58 AKT pathway 58 Tarvacin TM 58 interferon lambda 58 TroVax ® 58 CorVue ™ 58 metastatic CRC 58 Antigenics QS 58 AKT inhibitor 58 Carvedilol 58 teriflunomide 58 Naive Patients 58 Bayer Onyx 58 TNF inhibitor 58 CTGF 58 small molecule tyrosine 58 CTAP# Capsules 58 bendamustine HCl 58 Silodosin 58 BiTE Antibody 58 vapreotide acetate 58 HuMax CD4 58 Arranon 58 Progenitor Cells 58 BENICAR HCT 58 motesanib diphosphate 58 vemurafenib 58 GSK3B 58 5 HT6 receptor 58 ESBA# 58 Ceflatonin 58 demethylating agent 58 beta adrenergic 58 Kinoid 58 LT NS# 58 denileukin diftitox 58 VEGF inhibitor 58 JAK inhibitors 58 enzyme inhibitor 58 tumor necrosis 58 OvaRex MAb 58 siRNA mediated 58 peptide CGRP 58 Antibody Drug Conjugate 58 neratinib 58 SUTENT ® 58 BAL# [001] 58 radiolabeled monoclonal antibody 58 mineralocorticoid receptor 58 intratumoral 58 murine model 58 RoACTEMRA 58 peripherally restricted 58 Taxotere ® 58 beta1 58 factor Xa 58 gemcitabine Gemzar 58 humoral responses 58 antiplatelet medications 58 gastrointestinal stromal tumors GIST 58 Cloretazine VNP#M 58 dose proportionality 58 Pfizer Sutent 58 Files IND 58 Ag Ab Combo 58 CCR9 58 Hematopoietic 58 SSc 58 anti CD3 antibody 58 TLR agonists 58 replicon 58 Transcription Factor 58 Campath alemtuzumab 58 virotherapy 58 SGLT 58 Elotuzumab 58 somatostatin analogues 58 intranasal formulation 58 vascular disrupting agent 58 antitumour 58 CanAg 58 Cannabinoid 58 ACE Inhibitor 58 EGFR inhibitors 58 REMINYL ® 58 ATL/TV# 58 uricase 58 biliary tract cancer 58 myeloproliferative diseases 58 TNF Tumor Necrosis Factor 58 canagliflozin 58 ibritumomab tiuxetan 58 Imprime PGG 58 protease activated 58 protein tyrosine phosphatase 58 pediatric acute lymphoblastic 58 FDA Okays 58 Etanercept 58 Dendritic Cells 58 Prolongs Survival 58 Adalimumab 58 inducible nitric oxide synthase 58 Nilotinib 58 immunotherapeutic agent 58 Methotrexate MTX 58 Cytotoxicity 58 muscarinic 58 selective adenosine 58 CD4 + CD# 58 Cannabinor 58 adrenoceptor 58 OncoVEX GM CSF 58 prucalopride 58 S/GSK# 58 TransVax ™ 58 HSP# inhibitor 58 anti androgen 58 5 lipoxygenase 58 radiation sensitizer 58 Annexin V 58 NKG2D 58 Panzem R 58 hematological parameters 58 Virologic 58 Nod1 58 Immunogenicity 58 inhibit EGFR 58 adjuvant cisplatin 58 humanized monoclonal 58 cytotoxic T lymphocyte 58 glycoprotein GP IIb IIIa 58 mda 7 58 fulvestrant 58 Mutational 58 epithelial tumors 58 methyl D aspartate 58 CCR5 inhibitor 58 selectively inhibit 58 nilotinib Tasigna 58 tyrosine kinase inhibitor TKI 58 mitogenic 58 Adjuvant Treatment 58 vimentin 58 Nektar proprietary 58 costimulatory 58 IGF1R 58 somatostatin receptors 58 acadesine 58 tipifarnib 58 MDR1 58 Histologic 58 Sym# 58 NPM1 mutation 58 humanized therapeutic 58 Glatiramer acetate 58 receptor blocker 58 Nexavar ® 58 CD# ligand 58 oral antiviral 58 gp# protein [002] 58 myelofibrosis polycythemia vera 58 antibody MT# 58 HCV protease inhibitors 58 talabostat 58 BEXXAR Therapeutic Regimen 58 IFN γ 58 Olaparib 58 histone deacetylase 58 multitargeted 58 trastuzumab Herceptin ® 58 TÎ ² 4 58 engineered RAP peptides 58 QbG# 58 Anti angiogenic 58 chloride secretion 58 lymphoid malignancies 58 PI3K/mTOR 58 Panzem NCD 58 PORxin TM 58 interleukin IL 58 SCH # 58 MKC# MT 58 resolvins 58 regorafenib 58 carcinoembryonic antigen 58 glatiramer acetate 58 PDE# inhibitors 58 Systemic lupus erythematosus SLE 58 CEQ# 58 EpCAM 58 siRNA knockdown 58 Severe Sepsis 58 PARP inhibition 58 Septin 9 58 velafermin 58 XmAb# 58 ELISPOT 58 plasma pharmacokinetics 58 ABL1 58 Intravascular 58 Pharmacodynamics 58 Mimetics 58 treatment naive genotype 58 ORENCIA ® 58 ovarian cancer chronic hepatitis 58 rhIL 7 58 Eli Lilly Cymbalta 58 NSCLC tumors 58 AFREZZA TM 58 metastatic malignant 58 PKC# 58 selective A2A adenosine receptor 58 IL #R 58 plasma renin activity 58 HER1 58 epigenetic therapies 58 oral rivaroxaban 58 RhuDex R 58 tipranavir 58 Novel Oral 58 Omacetaxine 58 NeoLipid R 58 Adjuvant Chemotherapy 58 HLA DR2 58 Lubiprostone 58 Simulect 58 SynCon TM DNA 58 RRM1 58 DOXIL 58 humanised antibody 58 LHRH 58 Amrubicin 58 CDDO Im 58 genomic biomarker 58 Autoimmune Disorders 58 neoadjuvant treatment 58 telomerase inhibitors 58 selective estrogen receptor modulator 58 EOquin TM phase 58 CDK inhibitor 58 angiotensin II receptor blocker 58 sunitinib malate 58 efalizumab 58 STRIDE PD 58 OXi# 58 LPA1 receptor 58 Chronic Lymphocytic Leukemia CLL 58 HLA DR4 58 orally bioavailable 58 soluble receptor 58 BLyS specific 58 lumiliximab 58 JVRS 58 BCG refractory 58 vitro cytotoxicity 58 alteplase 58 novel peptide 58 monoclonal antibody mAb 58 histological subtype 58 neutralizing antibody 58 integrin alpha 58 topically administered 58 P gp 58 PEGylated interferon 58 intravenous recombinant 58 nilotinib 58 Trandolapril 58 AGTR1 58 Mg Uk 58 Gefitinib 58 refractory chronic lymphocytic 58 FGFR1 58 Introgen ADVEXIN 58 EGFR tyrosine kinase inhibitors 58 efficacy tolerability 58 pro angiogenic 58 favorable pharmacokinetic profile 58 decitabine 58 RECIST Response Evaluation Criteria 58 TRO# 58 Annamycin 58 DFMO 58 Proteasome 58 gemcitabine cisplatin 58 TNF blocker 58 DOS# 58 Protease Inhibitors 58 Fondaparinux 58 Q#IR 58 MAGE A3 58 Anidulafungin 58 PsA 58 IGFBP 3 58 IMA# 58 ChronVac C ® 58 oral FTY# 58 Anthrax Toxin 58 CA4P 58 Hematopoietic Stem Cells 58 TWYNSTA 58 ara C 58 Tanespimycin 58 omacetaxine mepesuccinate 58 EGS# 58 dimeglumine 58 pharmacodynamic endpoints 58 anti angiogenic agents 57 Solorel TM 57 Anticalin R 57 isoform selective 57 envelope glycoprotein 57 samalizumab 57 Granulocyte Colony Stimulating Factor 57 urothelial carcinoma 57 5 HT4 receptor 57 anaphylactic reactions bronchospasm 57 poly ADP ribose polymerase 57 alpha adrenergic 57 rxRNA 57 Kinesin Spindle Protein KSP 57 protein kinase inhibitor 57 Xeomin ® 57 somatostatin analogue 57 antiangiogenic activity 57 Cyclosporine 57 Saxagliptin 57 CTLA4 Ig 57 tumor xenograft models 57 erythropoietic 57 Phase 2b Clinical Trial 57 PDX pralatrexate 57 volociximab 57 CCR2 57 combinability 57 CD8 T cell 57 reslizumab 57 Aptivus ® 57 PrevOnco ™ 57 Fluorouracil 57 sd rxRNA 57 Potent Anti 57 Lung Cancer Drug 57 sunitinib Sutent ® 57 eTag assays 57 antisense inhibitor 57 bleomycin 57 anti amnesic 57 Immunohistochemical 57 receptor inhibitor 57 renin angiotensin aldosterone 57 canakinumab 57 antitumor effect 57 PEG IFN 57 EGF receptor 57 PC# cells 57 Doxorubicin 57 INC# 57 malignant ascites 57 #HT#A 57 imatinib resistant 57 HCV SPRINT 57 tumor histology 57 multikinase inhibitor 57 Myelofibrosis 57 HIF 1a 57 TBC# 57 Combo Therapy 57 TNF alpha inhibitor 57 nucleoside analog 57 AAG geldanamycin analog 57 Bruton tyrosine kinase 57 ATL# [002] 57 metabotropic glutamate receptors 57 GRNVAC1 57 Calcitonin 57 capsular polysaccharide 57 MyVax R 57 edifoligide E2F Decoy 57 infliximab Remicade 57 immune modulating 57 Removab 57 investigational protease inhibitor 57 NS5B polymerase 57 rFVIIa 57 Transdermal Delivery 57 SinuNase TM 57 VEGFR1 57 pretargeting 57 receptor inhibiting monoclonal 57 AlloMap 57 directed radiotherapeutic antibody 57 cytostatic 57 acute GvHD 57 Pafuramidine 57 HCV polymerase 57 PAM4 57 demonstrated antitumor activity 57 CD# antibody [001]